Skip to content

8-KAccepted Jan 21, 8:11 AM ET

Revance Therapeutics, Inc. 8-K

Revance Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

8:11 AM

Jan 21, 2025

Filed

Jan 21, 2025

Documents

14

Size

255.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.